McDonnell MB

Diamond Therapeutics, Inc., Toronto, ON M5X 1B8, Canada.

1 paper · 2 preprints · ORCID

ArticlePsilocybin

A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults.

Levy-Cooperman N, Sellers E, Glue P +5

Europe PMC2026
PreprintPsilocybin

Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure–Response Model

Tyler WJ, Sellers E, McDonnell MB

Europe PMC2026
PreprintPsilocybin

A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults

Levy-Cooperman N, Sellers E, Glue P +5

Europe PMC2026